ARCHIVES

FDA Approves Gleevec For First Line Rx Of CML

This article is from The Cancer Letter archive.

Vol. 26 No. 1 | January 31, 2003

Download PDF Visit The Full Archive

Related Articles

Bush Signs HHS Appropriations; NCI Budget $4.188B After Administrative Rescission.

January 11, 2002

NCI, CDC To Collaborate On Surveillance System.

March 24, 2000

Mammography Panel Reaches Consensus On Most Issues

September 23, 1977

In Brief: Elion, Schein, Johnson Head Societies; Phillips, Salmon Elected; McIntire, Pistenma to Leave NCI

June 3, 1983

FDA Approves Bexxar For Treatment Of Non-Hodgkin’s Lymphoma.

July 4, 2003

Taxol Patents Reveal Bristol Strategy to Safeguard Market Against Competitors

July 4, 1997